JG
BSTG

Jefferies Group’s Biostage, Inc. Common Stock BSTG Stock Holding History

Jefferies Group’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$238K – 2544
2013
Q4 		$238K Buy
+50,000
New +$234K ﹤0.01% 1496

Other funds holding BSTG

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Jefferies Group's BSTG Position: Q1 2014 in Review

Jefferies Group sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2014, closing a stake of 50,000 shares — an estimated $238K sold.

Jefferies Group first reported a position in BSTG in Q4 2013 and held it in 1 quarter. The position peaked at $238K in Q4 2013. 51 funds tracked by Wall St. Rank hold BSTG as of Q1 2014.

  • Jefferies Group reported no remaining Biostage, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Jefferies Group sold 50,000 Biostage, Inc. Common Stock shares in Q1 2014, an estimated $238K.
  • Jefferies Group first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Jefferies Group's Biostage, Inc. Common Stock position peaked at $238K in Q4 2013.
  • 51 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2014.

Based on Jefferies Group's 13F filing for Q1 2014, filed 16 May 2014.